Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tibolone vs E2V/MPA for Menopausal Symptoms
NCT01822288Phase 4Completed
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Nov 2012
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label trial of tibolone in menopause (2 arms), sponsored by Far Eastern Memorial Hospital. Primary endpoint: Menopausal symptoms at 12 weeks. Started Nov 2012; status: completed.
02
Drugs
tibolone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT01822288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01822288.